TY  - JOUR
AB  - In 2000, Millennium Pharmaceuticals was the poster child for successful genomic companies. Millennium's fast growth and exuberant valuations were due to the elegant alliances the company had forged with top pharmaceutical, biotechnology, and agricultural companies. However, as the market shifted and Millennium was forced to fully integrate, the type and structure of its alliances no longer worked.To illustrate how strategic alliances are used in biotechnology as growth tools and to demonstrate the impact of market conditions on the evolution of alliances.
VL  - 
IS  - 
SN  - 2474-6568
DO  - 10.1108/case.kellogg.2016.000037
UR  - https://doi.org/10.1108/case.kellogg.2016.000037
AU  - Löffler Alicia
AU  - Solf Markus
AU  - Zajac Edward J.
PY  - 2017
Y1  - 2017/01/01
TI  - Bayer and Millennium Pharmaceuticals: Success Based on Perfect Interaction
T2  - Kellogg School of Management Cases
PB  - Kellogg School of Management
SP  - 1
EP  - 20
Y2  - 2024/04/25
ER  -